Cancer diagnostics News and Research

RSS

New micro-scale technology holds promise for improved tumor diagnosis

Using a single-needle biopsy and new technology for tumor diagnosis developed by Baylor College of Medicine and the Broad Institute of MIT and Harvard, researchers have been able to provide a more detailed and wider window into cancer biology, tumor type and the mechanisms of response and resistance to therapy than with conventional approaches.

27 Jan 2020

Researchers confirm safety of cancer-specific PET probe in first-in-human clinical studies

A group of researchers led by Assistant Professor WATABE Tadashi of the Graduate School of Medicine of Osaka University achieved the stable domestic production of automatic synthesis modules for positron emission tomography (PET) probe F-18 NKO-035, a LAT1-selective amino acid derivative radiolabeled with 18F, confirming its safety in first-in-human clinical studies conducted at Osaka University Hospital in November 2019.

22 Jan 2020

Decline in advanced stage cancer diagnoses following health insurance expansion

Advanced stage cancer diagnoses declined following health insurance expansion in Massachusetts, likely due to increased access to screening and diagnostic services that identified cancers earlier, according to new research led by health economists at the University of Pittsburgh Graduate School of Public Health.

22 Jan 2020

Patient enrollment in potentially life-extending clinical trials is low

Patient enrollment in clinical trials as the first course of treatment after cancer diagnosis is low, despite the fact that enrollment may increase life expectancy, according to researchers at Penn State.

20 Jan 2020

Virtual reality during chemotherapy could help improve breast cancer patients' quality of life

Virtual Reality during chemotherapy has been shown to improve breast cancer patients' quality of life during the most stressful treatments, according to a recent study.

20 Jan 2020

New melanoma test may better predict recurrence and improve patient care

Researchers at Brigham and Women's Hospital have developed a new technique that improves on the current method for assessing whether primary melanoma is likely to recur and spread, following surgical removal.

20 Jan 2020

Rapid diagnosis centers cut waiting times for patients with non-specific symptoms

A rapid diagnosis centre has cut waiting times for patients with non-specific symptoms who may have cancer from 84 days to 6, and costs less than current usual care if used at more than 80% of capacity, a new study by Swansea University researchers and NHS colleagues has shown.

14 Jan 2020

NUS researchers discover new personalized tool for cancer diagnosis

A team of researchers from the National University of Singapore has discovered a new personalized tool to detect cancer, predict patient survivability and how well a cancer patient would respond to immunotherapy.

14 Jan 2020

Study demonstrates accuracy of AI system in diagnosing prostate cancer

The Lancet Oncology has today published the results of a study demonstrating the accuracy of an artificial intelligence system in diagnosing prostate cancer in tissue samples.

10 Jan 2020

Adequate health insurance could reduce racial outcome disparities in breast cancer

Lack of insurance coverage is a major cause of delayed breast cancer screening and treatment among minority women, which could lead to a decrease in a patient's chance of survival.

9 Jan 2020

Prostate cancer deaths are on the rise, shows new ACS report

Despite most cancers seeing a drop in deaths, prostate cancer deaths are on the rise in the U.S. New reporting from the American Cancer Society shows that in 2020, the number of men who will die from prostate cancer will hit a record high over the last two decades, with an increase of 5 percent since just last year.

9 Jan 2020

Study highlights the prevalence of alcohol use among cancer survivors

New research in the January 2020 issue of JNCCN-Journal of the National Comprehensive Cancer Network uses data from the National Health Interview Survey from 2000 to 2017 to examine self-reported drinking habits among people reporting a cancer diagnosis.

8 Jan 2020

New antibody-drug conjugate shows promising activity in salivary gland tumors

The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology.

7 Jan 2020

National veteran dataset will help dissect the relationship between mental illness and prostate cancer

There appears to be an unhealthy synergy between mental illness and prostate cancer, and researchers are working to dissect the relationship by first assembling the largest dataset ever of veterans with either condition or both.

23 Dec 2019

AI identifies previously unknown features relevant to cancer prognosis

Artificial intelligence technology developed by the RIKEN Center for Advanced Intelligence Project in Japan has successfully found features in pathology images from human cancer patients, without annotation, that could be understood by human doctors.

18 Dec 2019

New kind of AI improves breast cancer risk prediction

Researchers have established a new artificial intelligence (AI) that can identify women with increased risk of breast cancer.

17 Dec 2019

CPCRN releases supplemental issue of Preventive Medicine

In 2019, nearly 2 million Americans will receive a cancer diagnosis and more than 600,000 will die of cancer.

17 Dec 2019

African-Americans at higher risk for cancer-associated VTE, study finds

African-Americans are at higher risk for cancer-associated venous thromboembolism (VTE) as compared with patients from other races.

16 Dec 2019

New study assesses causes of death after breast cancer diagnosis

Survival rates for patients with breast cancer have improved significantly in the last four decades, and many patients will eventually die from non-cancer-related causes.

16 Dec 2019

Molecular subtyping of bladder tumors outperformed by standard pathology tests

While trying to develop a comparatively easy, inexpensive way to give physicians and their patients with bladder cancer a better idea of likely outcome and best treatment options, scientists found that sophisticated new subtyping techniques designed to do this provide no better information than long-standing pathology tests.

14 Dec 2019